The HLA-A-B-C Monoclonal Antibody (PE/Cyanine7 Conjugated, W6/32) is a valuable tool for researchers studying human leukocyte antigen (HLA) molecules. This antibody, offered by Assay Genie, is specifically designed to target the HLA-A, -B, and -C antigens, which play a crucial role in immune recognition and response.The W6/32 monoclonal antibody is conjugated with PE/Cyanine7, allowing for easy visualization and detection in flow cytometry and immunofluorescence applications. Its high specificity and sensitivity make it ideal for a wide range of research projects focused on HLA molecules and their involvement in immune responses, transplantation, autoimmune diseases, and infectious diseases.
By using the HLA-A-B-C Monoclonal Antibody (PE/Cyanine7 Conjugated, W6/32) from Assay Genie, researchers can gain valuable insights into the expression and function of HLA antigens in diverse biological samples, ultimately advancing our understanding of immune system regulation and disease pathogenesis.
Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum:
Swissprot:
P04439 P01889 P10321
Gene ID:
3105
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.